SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

J. B. Chemicals & Pharmaceuticals gets USFDA’s nod for Amitriptyline Hydrochloride Tablets

25 Jun 2025 Evaluate

J. B. Chemicals & Pharmaceuticals has received approval from United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Amitriptyline Hydrochloride Tablets USP, 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, and 150 mg. Amitriptyline Hydrochloride Tablets is indicated for relief of symptoms of depression.

J. B. Chemicals & Pharmaceuticals is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and APIs.

JB Chem & Pharma Share Price

1968.70 -9.30 (-0.47%)
16-Apr-2026 13:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1678.40
Dr. Reddys Lab 1223.00
Cipla 1231.55
Zydus Lifesciences 938.05
Lupin 2307.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×